When Should We Start Using Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Diabetic Kidney Disease?

Journal Title: Нирки - Year 2017, Vol 6, Issue 1

Abstract

International guidelines do not recommend angiotensin converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs) usage in the first stage of diabetic kidney disease. It shows the view, based on a small statistical sample, that olmesartan (or possibly other ACE inhibitors/ARBs) should be used to prevent the transition of the first stage of diabetic kidney disease to the second one in type 2 diabetes mellitus.

Authors and Affiliations

D. D. Ivanov

Keywords

Related Articles

Diagnostic and Predictive Value of Urinary Neutrophil Gelatinase-Associated Lipocalin in Acute Kidney Injury in Full-Term Infants with Severe Perinatal Pathology

The objective of the work was to determine diagnostic and predictive value of urinary neutrophil gelatinase-associated lipocalin in case of acute kidney injury in full-term infants with signs of severe perinatal patholog...

Hypomagnesemia in Chronic Kidney Disease: Problem or Individual Characteristics of Certain Patients?

The article considers the problem of magnesium deficiency in patients with chronic kidney disease. It requires special attention from clinicians due to the increased risk of cardiovascular complications. The study reveal...

Effect of Herbal Preparation Canephron® N on the Course of Diabetic Nephropathy in Patients with Diabetes Mellitus Type 2: Results of a Comparative Cohort Study

The Objective of the Study. Diabetic nephropathy (DN) is a severe and common complication of diabetes mellitus, leading to end-stage renal failure in 30 % of patients with diabetes mellitus. The first manifestation of DN...

Drug treatment of urolithiasis using citrate therapy

Urolithiasis - disease, morphological substrate of which is the formation of stones in the urinary tract and related changes in the urinary tract. The disease is characterized by its prevalence and a variety of etiologic...

CAKUT-Syndrome and Chronic Kidney Disease: the Concept of Nephrology Approach

This article presents the results of the analysis of the etiological structure of chronic kidney disease (CKD) in Kyiv children from 2006 to 2015. In the structure of CKD, CAKUT-syndrome dominates — from 62.3 % (2013) to...

Download PDF file
  • EP ID EP208749
  • DOI 10.22141/2307-1257.6.1.2017.93781
  • Views 96
  • Downloads 0

How To Cite

D. D. Ivanov (2017). When Should We Start Using Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Diabetic Kidney Disease?. Нирки, 6(1), 31-35. https://europub.co.uk/articles/-A-208749